64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas

(2013) Sibaprasad Bhattacharyya et al.   NUCLEAR MEDICINE AND BIOLOGY

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

(2013) M. J. Selby et al.   Cancer Immunology Research

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

(2012) Jeffrey S. Weber et al.   JOURNAL OF CLINICAL ONCOLOGY

Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology

(2012) Scott M. Knowles et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypophysitis Induced by Monoclonal Antibodies to Cytotoxic T Lymphocyte Antigen 4: Challenges from a New Cause of a Rare Disease

(2012) F. Torino et al.   ONCOLOGIST

Exploration of target molecules for molecular imaging of inflammatory bowel disease

(2011) Kei Higashikawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Soluble CTLA-4 Splice Variant Protects From Type 1 Diabetes and Potentiates Regulatory T-Cell Function

(2011) K. D. Gerold et al.   DIABETES

The mechanisms of cancer immunoescape and development of overcoming strategies

(2011) Tomonori Yaguchi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Overexpression of the CTLA-4 Isoform Lacking Exons 2 and 3 Causes Autoimmunity

(2011) S. M. Liu et al.   JOURNAL OF IMMUNOLOGY

Ipilimumab

(2011) Vernon K. Sondak et al.   NATURE REVIEWS DRUG DISCOVERY

Cancer immunotherapy – revisited

(2011) W. Joost Lesterhuis et al.   NATURE REVIEWS DRUG DISCOVERY

Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts

(2010) Bishnuhari Paudyal et al.   CANCER SCIENCE

Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals

(2010) J. Mitsui et al.   CLINICAL CANCER RESEARCH

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

(2010) E C Dijkers et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922

(2010) W. B. Nagengast et al.   JOURNAL OF NUCLEAR MEDICINE

Molecular mechanism and function of CD40/CD40L engagement in the immune system

(2009) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice

(2009) M. Araki et al.   JOURNAL OF IMMUNOLOGY

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

(2009) G. Niu et al.   JOURNAL OF NUCLEAR MEDICINE